
谭勇品读医药风云
| Publishes | Daily | Episodes | 1351 | Founded | 2 years ago |
|---|---|---|---|---|---|
| Language | Number of Listeners | Categories | PhilosophySociety & CultureNewsBusiness News |

回顾百奥赛图在资本市场一路走来,2022年,公司在港交所挂牌,完成了“国际验证”阶段,从搭建全球营销网络,到建立海外团队,再到吸引跨国药企合作。2025年,公司再次选择登陆A股科创板,标志着公司进入“本土价值实现”阶段,开始更强烈地与国内医药创新生态链接,寻求与其技术底座与收入结构更贴合的估值体系。当然,驱动百奥赛图这次登陆A股的核心,也是基于财务成熟与业务确定性的长期考量。与多数仍需资本输血的Biotech不同,百奥赛图已展现出健康的自我造血能力:2025年上半年,公司营收达6.21亿元,同比... more
近年来,在创新药行业经历资本周期波动、一级市场投资趋于理性、二级市场对盈利能力产生更严苛要求的背景下,Biotech公司的资本路径选择已经不仅是简单的融资方式,还成为商业模式、技术路线、生态融入能力和长期价值的集体检验。市场越来越强调技术驱动、业绩可验证、商业可持续兼具的公司。在这一背景下,百奥赛图敲钟科创板更具代表性意义。其“先H后A”两地上市的背后,是一家已实现盈利、现金流健康、硬核技术驱动的平台型Biotech正进入资本市场审视的聚光灯下,直面关于确定性与可持续性的核心拷问。上市首日,百奥... more
血液疾病领域可谓“全面开花”。最具代表性的莫过于CAR-T赛道。复星凯瑞的阿基仑赛注射液、合源生物的纳基奥仑赛注射液、药明巨诺的瑞基奥仑赛注射液、驯鹿生物的伊基奥仑赛注射液以及科济药业(恺兴生命科技)的泽沃基奥仑赛注射液等5款CAR-T产品集体进入商保创新药目录,为2025年的创新支付突破建立里程碑。除此之外,在血液肿瘤领域,多款双抗和小分子新药也成功准入基本医保和商保创新药目录。例如,在淋巴瘤领域,“罗氏打败罗氏”的戏剧性一幕再度上演。自去年罗氏的优罗华,即CD79b ADC维泊妥珠单抗成功准... more
首先,从企业层面看,多家跨国药企携“全球明星产品”成功跻身医保目录。
最典型的是近期市值突破万亿美元的礼来,其重磅产品替尔泊肽上市不到一年便成功进入目录,医保支付范围涵盖成人2型糖尿病血糖控制。今年前三季度,替尔泊肽实现全球总销售248.37亿美元,占礼来总营收近半,增速高达125%。
如今,这款全球“超级爆品”正式进入中国医保体系,其市场放量将进入加速阶段。值得注意的是,司美格鲁肽的糖尿病适应证此前已在医保内,替尔泊肽与司美格鲁肽将在医保支付框架下正面对抗。
阿斯利康则成为本次调整中跨国药企最... more
主播内容很好,但普通话程度不易听懂。建议使用AI阅读或找个普通话标准的人播音
How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.
Apple Podcasts | #33 | |
Apple Podcasts | #201 |
Listeners, social reach, demographics and more for this podcast.
| Listeners per Episode | Gender Skew | Location | |||
|---|---|---|---|---|---|
| Interests | Professions | Age Range | |||
| Household Income | Social Media Reach | ||||
Rephonic provides a wide range of podcast stats for 谭勇品读医药风云. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to 谭勇品读医药风云 and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.
Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for 谭勇品读医药风云, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.
Rephonic provides comprehensive predictive audience data for 谭勇品读医药风云, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.
To see how many followers or subscribers 谭勇品读医药风云 has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.
These podcasts share a similar audience with 谭勇品读医药风云:
谭勇品读医药风云 launched 2 years ago and published 1351 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.
Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.
Rephonic pulls ratings and reviews for 谭勇品读医药风云 from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.
View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.
Rephonic provides full transcripts for episodes of 谭勇品读医药风云. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.